Jae Kim's most recent trade in Lumentum Holdings Inc was a trade of 1,413 Common Stock done at an average price of $232.2 . Disclosure was reported to the exchange on Nov. 15, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lumentum Holdings Inc | Jae Kim | SVP, GENERAL COUNSEL | Payment of exercise price or tax liability using portion of securities received from the company at price $ 232.15 per share. | 15 Nov 2025 | 1,413 | 39,937 (0%) | 0% | 232.2 | 328,028 | Common Stock |
| Lumentum Holdings Inc | Jae Kim | SVP, GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 234.14 per share. | 15 Nov 2025 | 1,367 | 38,570 (0%) | 0% | 234.1 | 320,069 | Common Stock |
| Lumentum Holdings Inc | Jae Kim | SVP, GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 246.00 per share. | 15 Nov 2025 | 170 | 38,400 (0%) | 0% | 246 | 41,820 | Common Stock |
| Lumentum Holdings Inc | Jae Kim | SVP, GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Aug 2025 | 7,715 | 41,180 (0%) | 0% | 0 | Common Stock | |
| Lumentum Holdings Inc | Jae Kim | SVP, GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 116.73 per share. | 22 Aug 2025 | 3,407 | 34,565 (0%) | 0% | 116.7 | 397,690 | Common Stock |
| Lumentum Holdings Inc | Jae Kim | SVP, GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 117.36 per share. | 22 Aug 2025 | 1,100 | 33,465 (0%) | 0% | 117.4 | 129,092 | Common Stock |
| Lumentum Holdings Inc | Jae Kim | SVP, GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2025 | 11,633 | 41,453 (0%) | 0% | 0 | Common Stock | |
| Lumentum Holdings Inc | Jae Kim | SVP, GENERAL COUNSEL | Payment of exercise price or tax liability using portion of securities received from the company at price $ 117.43 per share. | 19 Aug 2025 | 5,538 | 37,972 (0%) | 0% | 117.4 | 650,327 | Common Stock |
| Lumentum Holdings Inc | Jae Kim | SVP, GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2025 | 2,057 | 43,510 (0%) | 0% | 0 | Common Stock | |
| Lumentum Holdings Inc | Jae Kim | SVP, GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 116.45 per share. | 15 Aug 2025 | 912 | 29,820 (0%) | 0% | 116.4 | 106,202 | Common Stock |
| Lumentum Holdings Inc | Jae Kim | SVP, GENERAL COUNSEL | Payment of exercise price or tax liability using portion of securities received from the company at price $ 115.86 per share. | 15 Aug 2025 | 802 | 30,732 (0%) | 0% | 115.9 | 92,920 | Common Stock |
| Septerna Inc | Jae B. Kim | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2025 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
| Lumentum Holdings Inc | Jae Kim | SVP, GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 77.98 per share. | 15 May 2025 | 4,577 | 31,534 (0%) | 0% | 78.0 | 356,914 | Common Stock |
| Lumentum Holdings Inc | Jae Kim | SVP, GENERAL COUNSEL | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.76 per share. | 15 May 2025 | 2,451 | 36,111 (0%) | 0% | 77.8 | 190,590 | Common Stock |
| Lumentum Holdings Inc | Jae Kim | SVP, GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Aug 2024 | 12,804 | 33,378 (0%) | 0% | 0 | Common Stock | |
| Lumentum Holdings Inc | Jae Kim | SVP, GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Aug 2024 | 4,732 | 38,110 (0%) | 0% | 0 | Common Stock | |
| Rambus Inc | Jae Kim | SVP, GC & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.21 per share. | 03 Feb 2021 | 2,993 | 129,279 (0%) | 0% | 19.2 | 57,510 | Common Stock |
| Avidity Biosciences Inc | Jae B. Kim | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2021 | 82,000 | 82,000 | - | - | Stock Option (Right to Buy) | |
| Rambus Inc | Jae Kim | SVP, GC & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 25,614 | 132,272 (0%) | 0% | 0 | Common Stock | |
| Rambus Inc | Jae Kim | SVP, GC & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 12,957 | 106,658 (0%) | 0% | 0 | Common Stock | |
| Rambus Inc | Jae Kim | SVP, GC & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.52 per share. | 01 Feb 2021 | 12,943 | 93,701 (0%) | 0% | 19.5 | 252,647 | Common Stock |